Skip to main content
SpringerLink
Log in

Biology of monoclonal antibodies in tumor therapy

  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

Abstract

This paper gives an overview of the biology of monoclonal antibodies in tumor therapy. The complexity of the monoclonal antibody concept is discussed with functional aspects on tumor antigen, antigen binding, Ig isotypes and effector mechanisms involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Currie G A: Eighty years of immunotherapy: A review of immunological methods used for the treatment of human cancer.BrJ Cancer 26, 141 (1972).

    CAS  Google Scholar 

  2. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predef'med specificity.Nature 256, 495 (1975).

    Article  PubMed  Google Scholar 

  3. Janson C H, Tehrani M J, Wigzell H, Mellstedt H: Rational use of biological response modifiers in hematological malignancies - A review of treatment with interferon, cytotoxic cells and antibodies.Leuk Res 13, 1039 (1989).

    Article  CAS  PubMed  Google Scholar 

  4. Janson C H, TehraniM J, Mellstedt H, Wigzell H: Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia. Characterization of the antibody,in vitro effector functions and results of therapy.Cancer lmmunol lmmunother 28, 225 (1989).

    CAS  Google Scholar 

  5. Klaus G G B, Pepys M B. Kitajima K, Askonas B A: Activation of mouse complement by different classes of mouse antibody.Immunology 38, 687 (1979).

    CAS  PubMed  Google Scholar 

  6. Denkers E Y, Badger C C, Ladbetter J A, Bernstein I D: Influence of antibody isotype on passive serotherapy of lymphoma.Jlmmuno1 135, 2183 (1985).

    CAS  Google Scholar 

  7. McConkey D J, Orrenius S, Jondal M: Cellular signalling in programmed cell death (apoptosis).lmmunol Today 11, 120 (1990).

    Article  CAS  Google Scholar 

  8. Goodman G E, Hellström L Brodzinsky L, Nicaise C, Kulander B, Hummel D, HeUström K E: Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian and lung cancer.J Clin Oncol 8, 1083 (1990).

    CAS  PubMed  Google Scholar 

  9. Lowder J, Meeker T, Campbell M, Garcia C F, Gralow L Miller R A, Warnke R, Levy R: Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: Correlation with clinical responses.Blood 69, 199 (1987).

    CAS  PubMed  Google Scholar 

  10. Jerne N K; Towards a network theory of the immune system.Ann Immunol 125c, 373 (1974).

    CAS  Google Scholar 

  11. Lanzavecchia A, Abrignani S, Scheidegger D, Obrist R, Dörken B, Moldenhauer G: Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets.J Exp Med 167, 345 (1988).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research Infection and Immunology, Astra Arcus AB, S-151 85, Södertäilje, Sweden

    Carl Harald Janson

Authors
  1. Carl Harald Janson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janson, C.H. Biology of monoclonal antibodies in tumor therapy. Med Oncol. & Tumor Pharmacother. 10, 21–23 (1993). https://doi.org/10.1007/BF02987764

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02987764

Key Words

Search

Navigation